Sage Journals: Discover world-class research

Abstract

Keywords

imatinib hearing loss ototoxicity nephrogenic systemic fibrosis

Get full access to this article

View all access options for this article.

References

Kay

High

. Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthritis Rheum. 2008;58:2543-2548.

Attili

Bapsy

Anupama

Lokanatha

. Irreversible sensorineural hearing loss due to imatinib. Leuk Res. 2008;32:991-992.

Janssen

Berendse

Schuurhuis

Merle

Ossenkoppele

. A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment. Am J Hematol. 2009;84:679-682.

Fritzsch

Pirvola

Ylikoski

. Making and breaking the innervation of the ear: neurotrophic support during ear development and its clinical implications. Cell Tissue Res. 1999;295:369-382.

Petit

. Genes responsible for human hereditary deafness: symphony of a thousand. Nat Genet. 1996;14:385-391.

Sensorineural Hearing Loss following Imatinib (Gleevec) Administration

Abstract

Keywords

Get full access to this article

References